These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
335 related items for PubMed ID: 28392495
1. Cocrystal solubility product analysis - Dual concentration-pH mass action model not dependent on explicit solubility equations. Avdeef A. Eur J Pharm Sci; 2017 Dec 15; 110():2-18. PubMed ID: 28392495 [Abstract] [Full Text] [Related]
2. Influence of Coformer Stoichiometric Ratio on Pharmaceutical Cocrystal Dissolution: Three Cocrystals of Carbamazepine/4-Aminobenzoic Acid. Li Z, Matzger AJ. Mol Pharm; 2016 Mar 07; 13(3):990-5. PubMed ID: 26837376 [Abstract] [Full Text] [Related]
4. Thermodynamic Solubility Profile of Carbamazepine-Cinnamic Acid Cocrystal at Different pH. Keramatnia F, Shayanfar A, Jouyban A. J Pharm Sci; 2015 Aug 07; 104(8):2559-65. PubMed ID: 26096952 [Abstract] [Full Text] [Related]
5. Cocrystal Solubility Product Prediction Using an in combo Model and Simulations to Improve Design of Experiments. Avdeef A. Pharm Res; 2018 Feb 02; 35(2):40. PubMed ID: 29396647 [Abstract] [Full Text] [Related]
7. Pharmaceutical characterisation and evaluation of cocrystals: Importance of in vitro dissolution conditions and type of coformer. Tomaszewska I, Karki S, Shur J, Price R, Fotaki N. Int J Pharm; 2013 Sep 10; 453(2):380-8. PubMed ID: 23727143 [Abstract] [Full Text] [Related]
9. Use of a glutaric acid cocrystal to improve oral bioavailability of a low solubility API. McNamara DP, Childs SL, Giordano J, Iarriccio A, Cassidy J, Shet MS, Mannion R, O'Donnell E, Park A. Pharm Res; 2006 Aug 10; 23(8):1888-97. PubMed ID: 16832611 [Abstract] [Full Text] [Related]
11. Improving Dissolution Rate of Carbamazepine-Glutaric Acid Cocrystal Through Solubilization by Excess Coformer. Yamashita H, Sun CC. Pharm Res; 2017 Dec 29; 35(1):4. PubMed ID: 29288433 [Abstract] [Full Text] [Related]
12. Investigation of Poor Solubility of a Salt-Cocrystal Hydrate: A Case Study of the Common-Ion Effect in Betrixaban, an Anticoagulant Drug. Devarapalli R, Indukuri A, Bollineni M, Mondal A, Reddy CM, Chennuru R. Mol Pharm; 2021 Mar 01; 18(3):1138-1149. PubMed ID: 33528261 [Abstract] [Full Text] [Related]
13. Mechanisms by which moisture generates cocrystals. Jayasankar A, Good DJ, Rodríguez-Hornedo N. Mol Pharm; 2007 Mar 01; 4(3):360-72. PubMed ID: 17488034 [Abstract] [Full Text] [Related]
17. Hansen solubility parameter as a tool to predict cocrystal formation. Mohammad MA, Alhalaweh A, Velaga SP. Int J Pharm; 2011 Apr 04; 407(1-2):63-71. PubMed ID: 21256944 [Abstract] [Full Text] [Related]
18. The effects of pH, surfactant, ion concentration, coformer, and molecular arrangement on the solubility behavior of myricetin cocrystals. Ren S, Liu M, Hong C, Li G, Sun J, Wang J, Zhang L, Xie Y. Acta Pharm Sin B; 2019 Jan 04; 9(1):59-73. PubMed ID: 30766778 [Abstract] [Full Text] [Related]
19. Pharmaceutical Cocrystal: An Antique and Multifaceted Approach. Panzade PS, Shendarkar GR. Curr Drug Deliv; 2017 Jan 04; 14(8):1097-1105. PubMed ID: 27758692 [Abstract] [Full Text] [Related]